Publicaciones en colaboración con investigadores/as de University Medical Center Utrecht (214)

2024

  1. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

    Nature Medicine, Vol. 30, Núm. 1, pp. 271-278

  2. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

  3. Impact of sex on the assessment of the microvascular resistance reserve

    International Journal of Cardiology, Vol. 402

  4. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

  5. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

    Travel Medicine and Infectious Disease, Vol. 57

2023

  1. A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 9, pp. 2497-2509

  2. A deep learning system for detection of early Barrett's neoplasia: a model development and validation study

    The Lancet Digital Health, Vol. 5, Núm. 12, pp. e905-e916

  3. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876

  4. A second update on mapping the human genetic architecture of COVID-19

    Nature

  5. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

    European heart journal, Vol. 44, Núm. 29, pp. 2659-2671

  6. Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry

    International Journal of Cardiology, Vol. 392

  7. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255

  8. EAACI guidelines on the diagnosis of IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076

  9. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

  10. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

    Cancers, Vol. 15, Núm. 16

  11. IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes

    Diabetes/Metabolism Research and Reviews, Vol. 39, Núm. 7

  12. Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements – DEFINE-FLOW core laboratory sub-study

    International Journal of Cardiology, Vol. 377, pp. 9-16

  13. Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry

    European heart journal, Vol. 44, Núm. 30, pp. 2862-2869

  14. Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

    Cancer Science, Vol. 114, Núm. 3, pp. 1026-1036

  15. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

    eClinicalMedicine, Vol. 57